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questionnaire. Whatever the level of pain reduction, the WTP value evaluated was 
different before and after surgery. The WTP were not correlated to the patients’ 
incomes. CONCLUSIONS: Although short-lived, avoidance of postoperative pain 
may have considerable value to patients undergoing a heavy surgery. These ﬁndings 
may have important consequences for selection of emerging analgesia technologies.
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OBJECTIVES: Inﬂuenza causes signiﬁcant morbidity and mortality particularly in the 
elderly where the vast majority of inﬂuenza related deaths occur among people aged 
q65 years of age. Vaccination is the most effective way to prevent inﬂuenza and its 
associated complications. Studies have shown that administering the inﬂuenza vaccine 
via the intradermal (ID) route results in signiﬁcantly superior immune responses 
compared with intramuscular (IM) administration. A WTP study using discrete choice 
conjoint analysis (CA) was designed to determine participant’s preference for ID 
inﬂuenza vaccination over the currently available IM injection. METHODS: Austra-
lians individuals aged 65 years and older were presented with a set of 12 pairs of 
choices describing the two vaccine types; 11 choices to determine WTP for variable 
levels and one to detect irrational trades. Each pair contained information for IM and 
ID vaccines regarding efﬁcacy, adverse event proﬁle, administration and cost. Values 
were randomly allocated based on the ranges for each attribute and each participant 
received a bespoke set of choices. The questionnaire sought basic demographic infor-
mation and was completed after a short presentation on inﬂuenza. RESULTS: Ninety 
people aged q65 years were recruited to participate in the study. Participants had an 
average age of 71.1 years (SD  4.0) and more than half (n  50, 56%) stated that 
they get immunised against inﬂuenza annually. Both the adjusted and unadjusted 
analyses for the CA showed a statistically signiﬁcant preference for ID injection with 
participants willing to pay an additional $25.80 for an ID vaccine and $26.80 when 
adjusted for demographic variables. The efﬁcacy difference of ID vs. IM was respon-
sible for driving preference and the ID needle also added to the overall WTP for the 
vaccine and was also statistically signiﬁcant. CONCLUSIONS: The participants 
clearly preferred to be vaccinated against inﬂuenza with an ID vaccine over an intra-
muscular vaccine.
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OBJECTIVES: To assess Canadian patient preferences and estimate willingness to 
pay for symptoms relief for gastroesophageal reﬂux disease (GERD) treatment. 
METHODS: The study was a cross-sectional design, recruiting patients enrolled in a 
multi-centre clinical trial from 17 Canadian clinical sites. Preferences and willingness 
to pay were estimated using a discrete choice experiment (DCE) informed by focus 
groups and clinical literature. The experimental design considered orthogonality, 
balance and efﬁciency. The pen-and-paper-administered DCE survey consisted of 14 
discrete choice tasks. Patients chose between 3 different GERD treatments described 
by 6 attributes: GERD medication cost, when medication was taken, diet changes, 
daytime discomfort due to GERD, sleeping discomfort due to GERD and side effects. 
Additional data were gathered on health status, health-related quality of life, and 
sociodemographic characteristics RESULTS: 361 of 379 subjects completed the DCE. 
Mean age was 57 years (S.D. 16); 48% were male; 41% paid some portion of prescrip-
tion drug costs; a majority rated their GERD symptoms as mild to moderate. Avoiding 
side effects was the most important attribute, followed by sleeping discomfort, daytime 
discomfort, dietary changes and medication cost. Treatment choice was least affected 
by when the medications were to be taken. Patients were willing to pay (WTP) $16 
for mild rather than moderate side effects and $14 for complete relief of nighttime 
symptoms rather than 1–3 episodes per month. Patients with less severe GERD symp-
toms were WTP more to avoid side effects. Older patients were less WTP for better 
relief than younger patients. Avoiding sleeping discomfort was more important to 
women. CONCLUSIONS: Patients are WTP more for a GERD medication that avoids 
side effects, nighttime and daytime discomfort and dietary changes. Differences in 
preferences were found by gender and age. This information can help to guide physi-
cians and patients in choosing GERD treatments.
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OBJECTIVES: Increased competition in the health sector has led hospitals and other 
care institutions to explore new allocation mechanisms that move away from tradi-
tional expert based care allocation to more commercially based allocation mecha-
nisms. Little is known however about consumer perceptions and evaluations of new 
commercial (price based) allocation mechanisms and how these perceptions and evalu-
ations may differ between individuals and treatments. This paper investigates how 
consumers evaluate (new) hospital care allocation mechanisms. METHODS: We used 
data of 577 respondents from an American consumer panel. To test the framework 
conﬁrmatory factor analysis was done and random parameter regression models were 
estimated. RESULTS: We found that offering individuals the opportunity to pay more 
for a higher chance of treatment (ﬂexible pricing) affects their perceptions of both the 
total (p  0.005) and distributional health outcomes (p  0.001) of a hospital’s care, 
which in turn affect consumer attitude towards the allocation mechanism (p  0.001 
and p  0.001). Furthermore, we found that the effects of these two key collective 
outcome perceptions on consumer attitude are moderated by the type of medical 
condition (life saving vs. life improving) (p  0.001 and p  0.003), by age (p  0.002 
and p  0.001), and to a lesser extent by gender (p  0.01 and n.s.). CONCLUSIONS: 
Knowing how consumers evaluate allocation mechanisms is important for hospitals 
because less acceptable allocation mechanisms may scare away patients and decrease 
community support towards the hospital. Therefore our ﬁndings can be relevant and 
helpful for hospitals that consider implementing new allocation policies.
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OBJECTIVES: Frequent attenders (FA) generate a large proportion of clinical work-
load, referrals and prescriptions in the primary care (PC). The aim of this study was 
to examine factors, which predict frequent attendance of the PC services in a long-term 
follow-up. Factors explaining the long-term frequent use of PC services have not been 
previously explored. METHODS: A prospective cohort study without intervention 
was carried out in the primary health care centre in Tampere, Finland. From a random 
sample of 200 PC FAs, 85 patients participated in the study. All participants were PC 
FAs in the ﬁrst study year. After four years follow-up the patients were classiﬁed as 
persistent or temporary FAs. A patient was considered as a persistent FA, if he visited 
the health centre at least 8 times a year for at least 3 out of 4 follow up years. In 
addition to clinical assessment, also the patient reported outcome assessment was 
comprehensive including e.g. 15D, BDI, SOC-13, TAS-20, SCL (somatisation part), 
Whitely Index, patient satisfaction, fear of death, and alcohol consumption. 59 dif-
ferent variables were examined as potential predictors using P-course, a web-based 
Bayesian prediction tool. The models were assessed with accuracy, and predictions 
with posterior odds and credibility intervals. RESULTS: According to the predictions, 
the most inﬂuential predictive factors related to persistent FAs were female gender, 
body mass index above 30, former frequent attendance, fear of death, alcohol absti-
nence, low patient satisfaction and irritable bowel syndrome. New observations 
related to FAs were high body mass index, alcohol abstinence, fear of death and irri-
table bowel syndrome. CONCLUSIONS: Our Bayesian model can be used for proac-
tive modelling of persistent FAs in uncertain situations. However, before its use in 
practice, the external validity of the model will need to be deﬁned, because we only 
used partitioning in the accuracy assessments and not independent data.
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OBJECTIVES: The social security system in Austria constringes insured people to pay 
a ﬁxed co-payment of a4.80 per prescribed drug unit. Under certain conditions insured 
are exempted (e.g. very poor people). In 2008 the Austrian government implemented 
a co-payment limit for prescription drugs, called REGO. If the insured have paid 2% 
of their annual net income for co-payment rates, they are exempted from these co-
payments for the rest of the year. We analyzed the effects of REGO on the prescription 
volume and therewith demand and on the total expenditures for prescription drugs. 
METHODS: We estimated hypothetical expenditures and prescriptions for 2008 
under the assumption that REGO had not been implemented, using the historical data 
of 2006, 2007 and 2008 on different autoregressive process models. RESULTS: Our 
analysis showed that the demand increases when prescription drugs become free, and 
